CTRI/2009/091/000075已完成未知
A randomised double- blind well controlled clinical trial to compare the efficacy and safety of rectally administered Misoprostol and Intravenous Oxytocin infusion in preventing intraoperative and postpartum blood loss in women undergoing caesarean section. - Misoprostol,rectal,blood loss,cesarean section
Chittaranjan Sevasadan HospitalSPMukherjee Road Kolkata0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •women undergoing elective or emergency caesarean section.
排除标准
- •Antepartum Haemorrhage,Severe Preeclampsia,Prolonged and Obstructed labour,Hb below 8gm/dl,Multiple Pregnancy,Polyhydramnios and associated Myoma of uterus,Cardiovascular,renal ,hepatic and connective tissue disorders.
研究者
相似试验
已完成
不适用
Randomised, controlled, double-blind clinical study on the effect of a functional milk-product on metabolism of men with diagnosed metabolic syndromeISRCTN41474531Humana GmbH (Germany)60
已完成
不适用
Effect of Functional milk product On the Metabolic Syndrome IIMetabolic syndromeNutritional, Metabolic, EndocrineISRCTN90960030Humana GmbH (Germany)240
招募中
不适用
The Comparison between two method of minisurgical percutaneous dilated tracheostomyThe relationship between two methods of small throat surgery through the skin.IRCT20150107020592N8Masih Daneshvari Hospital66
已完成
不适用
evaluation of the ability of a drug (Tranexamic acid) in reducing blood loss during and after surgery in head and neck cancer patientsCTRI/2018/05/014184AIIMS86
进行中（未招募）
1 期
clinical study on the efficacy of infiltrative echo-guided therapy with hyaluronic acid (500-730 KDa) (HYALGAN®) versus saline solution in the conservative treatment of Achilles tendinopathy. Subjects will be randomly assigned to one of these two groups of treatment. Both evaluator and patients are unaware of the treatment assigned. In the open label extension, patients with persistent pain can receive a second cycle of Hyalgan.Achilles tendinopathyEUCTR2013-004117-40-ITFidia Farmaceutici SpA54